DRUGS CONTROL ADMINISTRATION

GOVERNMENT OF TELANGANA
  • Home
  • Contact Us
  • Dept Login
  • Home
  • About Us
  • Services
  • Key Contacts
    • Hon'ble Minister
    • State Officers
    • Regional Officers
    • District Officers
    • Drugs Inspectors
  • Circulars & GOs
    • Circulars
    • GOs
  • Related Links
  • Gallery
  • Citizen Charter
  • Act & Rules
  • RTI Act
  • How To Apply
    1. Circular issued regarding certain instructions on sale of Oxytocin
    2. Circular issued regarding certain instructions on sale of Oxytocin
    3. Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017
    4. Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017
    5. Medical Devices Rules 2017
    6. Medical Devices Rules 2017
    7. List of Notified Bodies registered with CDSCO under Medical Devices Rules.
    8. List of Notified Bodies registered with CDSCO under Medical Devices Rules.
    9. Grouping guidelines for Medical Devices applications
    10. Grouping guidelines for Medical Devices applications
    11. FAQs on Medical Devices Rules
    12. FAQs on Medical Devices Rules
    13. Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs
    14. Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs
    15. Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A
    16. Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A
    17. Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019
    18. Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019
    19. GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY
    20. GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY
    21. Standards for Blood Banks and Blood Transfusion Services
    22. Standards for Blood Banks and Blood Transfusion Services
    23. Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers
    24. Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers
    25. Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices.
    26. Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines.
    27. Cosmetics Rules 2020
    28. Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices.
    29. Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines.
    30. Cosmetics Rules 2020
    31. Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious
    32. Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious
    33. Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal
    34. Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal
    35. Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence
    36. Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence
    37. GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal
    38. GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal
    39. Consequential Amendments to GSR 1337E Gazette Notification
    40. Consequential Amendments to GSR 1337E Gazette Notification
    41. New Drugs and Clinical Trial Rules 2019
    42. New Drugs and Clinical Trial Rules 2019
    43. FAQs on New Drugs and Clinical Trial Rules 2019
    44. FAQs on New Drugs and Clinical Trial Rules 2019

Main Menu

  • Objectives of DCA
  • Organisational Setup
  • Client's Charter
  • Statute Implemented
  • Performance of DCA

Public Services

  • Online Drugs Licensing System
  • DCG(I) Approved Drugs
  • Blood Banks
  • Banned Drugs
  • NSQ Drugs
  • Medical Stores
  • Manufacturing Units
  • Medical shops in Govt Hospitals
  • Consumer Awareness
  Your are Visitor #689810

Designed, Developed and Hosted by National Informatics Centre, Hyderabad.

Content owned, maintained and updated by Department of Drugs Control Administration, Government of Telangana